NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced its second quarter 2025 results. Earnings Return Per Share on Equity (ROE) 2Q 2025 2Q 2025 Net Income $1.03 ROE 11.7% Adjusted Earnings $2.02 Adjusted ROE 14.6% Net income was $698 million. Adjusted earnings declined to $1.4 billion, due to less favorable underwriting and lower investment margins, partially offset by volume growth and favorable expense m
Related Questions
How will the decline in adjusted earnings impact MetMet’s stock price in the short term?
How do the reported ROE (11.7%) and adjusted ROE (14.6%) compare to MetLife’s historical averages and peer benchmarks?
What drove the $698 million net income versus the $1.03 billion net income figure in the summary?
How does this quarter’s performance affect MetLife’s dividend policy and payout ratio?
What guidance does MetLife provide for Q3 2025 and the full‑year 2025 outlook regarding earnings and ROE?
What is the net impact of volume growth versus underwriting losses on the overall profit profile?
How do these results affect the risk profile of MetLife’s insurance and investment portfolios?
How might the reported results influence analyst earnings revisions and target price adjustments?
What are the implications for the company’s capital allocation strategy (share buybacks, acquisitions, etc.)?
How does the adjusted earnings decline compare to prior quarters and the same quarter last year?
How significant was the “favorable expense” offset and what expense categories drove it?
What caused the lower investment margins—e.g., lower bond yields, equity market performance, or asset allocation?
Why did adjusted earnings drop to $1.4 billion despite “volume growth” and what specific underwriting factors contributed?
What are the expectations for the upcoming earnings release in Q3 regarding the same metrics?
What were the “less favorable underwriting” issues—specific lines of business or geographic markets?